| abstract |
This invention relates to the use of compounds of formula (I), where -a = a-a = a- is a radical of the formula -CH = CH-CH = CH-, -N = CH-CH = CH-, -CH = N- CH = CH—, —CH = CH — N = CH—, —CH = CH — CH = N—, where each hydrogen atom may be optionally substituted; Q is a radical of the formula (b-1), (b-2), (b-3), (b-4), (b-5), (b-6), (b-7), (b- 8), G represents a direct bond or C-alkanediyl; R is an optionally substituted monocyclic heterocycle for the manufacture of a medicament for the treatment of viral infections, in particular RSV infections. Some compounds of formula (I) are new compounds. |